The Swiss Federation of Clinical Neuro-Societies (SFCNS) Swiss Brain Health Plan 2nd Stakeholder Meeting is set to take place at the Zentrum Paul Klee, Bern, on 5 December.

Our successful 2024 Advocacy Training participants talk about their experience and how the training has equipped them to champion brain health!

RRFS study provides insight into how junior neurologists across Europe perceive their access to training and certification in neurosonology, underlining the need for a more standardised approach.

As part of the EAN's mission to strengthen connections with its full institutional members, we interviewed leaders from various national neurological societies across Europe and beyond.

Young neurologists are invited to test and prove their preparation in next year's European Board Exam in Neurology, which will be held online on 9-10 May (oral) and 16 May (written) 2025.

Two esteemed Turkish colleagues, Prof. Nilda Turgut and Dr. Emel Ersöz passed away as a result of a tragic traffic accident during the 4th International Balkan Neurology and Neuroscience Congress in Tekirdağ on 11 October 2024.

Abstract submission and registration are NOW OPEN for the 11th Congress of the European Academy of Neurology!

We are excited to welcome our newly matched mentees to the EAN Mentorship Programme! Congratulations on starting this special journey toward your personal and career growth.

For the sixth consecutive year, we hosted a successful EAN Autumn School, offering three enriching days of neurological education in the beautiful surroundings of Loutraki, Greece on October 24-28.

We are delighted to announce another upcoming Webinar on Neuroimaging in CNS Inflammatory Disorders: Differentiating MS and Mimickers on Tuesday, 19 November 2024.

Interested in strengthening your advocacy skills to help raise the voice of brain health? Find out more about the EAN Advocacy Training programme, taking place March-June 2025.

Dr Giacomo Sferruzza, the new EAN Resident & Research Fellow Section (RRFS) Chair, gives an overview of the RRFS Office team, and their aims and priorities for the term ahead.

We are excited to announce the publication of our Sustainability Report 2024, which highlights the steps we have taken to integrate sustainable practices throughout our operations and supply chains.

Our paper of the month for November presents the findings from two large trials comparing the safety and efficacy of evobrutinib with teriflunomide in adults with a diagnosis of relapsing MS.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024.